8-KShareholder MattersRegulation FDExhibits & Filings

ALTRIA GROUP, INC. 8-K Report, Shareholder Vote Results (May 14, 2014)

Filed May 14, 2014For Securities:MO

Summary

Altria Group, Inc. (MO) filed an 8-K on May 14, 2014, detailing the results of its Annual Meeting of Shareholders held on May 14, 2014. The meeting saw a strong turnout, with over 86% of outstanding shares represented. Key outcomes included the overwhelming election of all eleven director nominees and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2014. Shareholders also provided advisory approval for the compensation of the company's named executive officers. In addition to routine corporate governance matters, the filing highlights that two shareholder proposals were defeated: one concerning health effect and cessation materials for less educated tobacco consumers, and another regarding the disclosure of lobbying policies and practices. The company also reaffirmed its 2014 guidance in a press release issued in connection with the meeting, though this information is furnished and not deemed "filed."

Key Highlights

  • 1Strong shareholder participation at the Annual Meeting, with 86.96% of outstanding shares represented.
  • 2All eleven director nominees were overwhelmingly elected, indicating strong board support.
  • 3PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2014 with significant shareholder approval.
  • 4Shareholders provided advisory approval for the compensation of Altria's Named Executive Officers.
  • 5Two shareholder proposals, one on health effect materials and another on lobbying disclosures, were defeated by a significant margin.
  • 6Altria reaffirmed its 2014 financial guidance in a press release associated with the meeting.

Frequently Asked Questions

The primary outcomes were the election of all director nominees, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and advisory approval of executive compensation. Two shareholder proposals regarding health effect materials and lobbying disclosures were defeated.

All eleven director nominees received substantial support, with 'For' votes ranging from over 1.15 billion to over 1.24 billion shares, indicating strong shareholder confidence in the board.

The defeat of the shareholder proposals suggests that the majority of voting shareholders did not support these specific initiatives, aligning with management's recommendations or views on these matters.

Yes, in a press release issued on May 14, 2014, in connection with the Annual Meeting, Altria reaffirmed its financial guidance for the fiscal year 2014. However, this information was furnished under Regulation FD and not deemed 'filed'.